Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Adderall XR, dextroamphetamine/amphetamine
Also known as: MAS XR (SLI 381)
print preview
bookmark
share with colleague
General Information
Company
Shire plc
Description
Extended-release formulation of Adderall, mixed salts of a single entity amphetamine
Molecular Target
Unknown
Mechanism of Action
Unknown
Latest Stage of Development
Marketed
Indication
Attention deficit hyperactivity disorder (ADHD)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy